Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Future Innovation Group, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 87%, Jul-Sep Ordinary Profit Increases by 5.8 times
4392 Future Innovation Group, Inc. 【J-GAAP】
Earnings ReportFuture Innovation Group, Inc. <4392> [TSE Prime] announced its financial results after the market closed on November 14th (15:35). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2025 (January to September) expanded 557 million yen, an increase 86.9% compared to the same period last year. However, Progress toward the full-year plan of 950 million yen was 58.6%, also falling below the five-year average of 78.0%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to December period (4Q) is expected to surge 4.1 times that of the same period last year, reaching 393 million yen.
In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit surged 5.8 times that of the same period last year, reaching 174 million yen. The operating profit margin significantly improved from 1.6% in the same period last year to 5.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Sep, 2023 | 10,273 | 586 | 587 | 412 | 13.7 | 82.1 | Nov 14, 2023 | J-GAAP |
| Jan - Sep, 2024 | 8,805 | 317 | 298 | 295 | 9.8 | 75.8 | Nov 14, 2024 | J-GAAP |
| Jan - Sep, 2025 | 9,936 | 565 | 557 | 630 | 20.8 | 58.6 | Nov 14, 2025 | J-GAAP |
| YoY | +12.8% | +78.2% | +86.9% | +113.6% | +112.6% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 6,154 | 93 | 125 | -1,707 | -56.5 | 5 | Feb 19, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 7,442 | 558 | 567 | 321 | 10.6 | 10 | Sep 29, 2025 | J-GAAP |
| YoY | +20.9% | +500.0% | +353.6% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 13,534 | 723 | 715 | 210 | 7.0 | 5 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 12,016 | 363 | 393 | -1,412 | -46.7 | 5 | Feb 19, 2025 | J-GAAP |
| Dec, 2025 Guidance | 14,050 | 950 | 950 | 651 | 21.4 | 10 | Sep 29, 2025 | J-GAAP |
| YoY | +16.9% | +161.7% | +141.7% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 2,943 | 47 | 30 | 0 | 0.0 | 1.6 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 3,211 | 46 | 95 | -1,707 | -56.5 | 1.4 | Feb 19, 2025 | J-GAAP |
| Jan - Mar, 2025 | 3,451 | 256 | 244 | 149 | 4.9 | 7.4 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 3,157 | 136 | 139 | 181 | 6.0 | 4.3 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 3,328 | 173 | 174 | 300 | 9.9 | 5.2 | Nov 14, 2025 | J-GAAP |
| YoY | +13.1% | +268.1% | +480.0% | - | +98,900.0% |
Related Articles
FREESIA MACROSS, First Half Ordinary Profit Increases by 28%, Jul-Sep Ordinary Profit Increases by 20%
Yamaichi Uniheim Real Estate, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Turns to Loss
LUCKLAND, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.2 times, Exceeded Record Profit Forecast, The Undecided Dividend Set at 20 Yen, Resuming Dividends for the First Time in Three Terms
AIMECHATEC, Jul-Sep (1Q) Ordinary Profit Turns to Profit
Delta-Fly Pharma, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
KLASS, 48% Increase in Ordinary Profit for The Current Fiscal Year
Giken Holdings, First Half Ordinary Profit Increases by 51%, Jul-Sep Ordinary Profit Increases by 2.1 times
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
VELTRA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 77%
LIFE CREATE, First Half Ordinary Profit Turns to Loss